- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Atypical Parkinsonism in Russian Federation
Total 30 results
-
St. Petersburg State Pavlov Medical UniversityTerminatedMyelodysplastic Syndromes | Leukemia, Chronic Myeloid | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeRussian Federation
-
Nobilis Therapeutics Inc.RecruitingParkinson DiseaseRussian Federation
-
Bial - Portela C S.A.CompletedParkinson's DiseaseFrance, Russian Federation
-
Atlas BiomedTerminatedParkinson Disease | Genetic PredispositionRussian Federation
-
AO GENERIUMCompletedAtypical Hemolytic Uremic Syndrome | aHUSRussian Federation
-
GlaxoSmithKlineCompletedParkinson DiseaseUnited States, Estonia, Korea, Republic of, Russian Federation, Slovakia
-
Solvay PharmaceuticalsCompletedAdvanced Stage Parkinson's DiseaseArgentina, United States, Brazil, Bulgaria, Canada, Chile, Colombia, Latvia, Lithuania, Peru, Russian Federation, Ukraine
-
AbbVieActive, not recruitingParkinson's Disease (PD)United States, Australia, Belgium, Canada, Denmark, Germany, Italy, Japan, Netherlands, Russian Federation, Spain, Sweden, United Kingdom
-
Alexion Pharmaceuticals, Inc.CompletedAtypical Hemolytic Uremic Syndrome (aHUS)United States, France, Spain, Taiwan, United Kingdom, Australia, Belgium, Germany, Italy, Japan, Korea, Republic of, Russian Federation, Austria, Canada
-
Solvay PharmaceuticalsCompletedAdvanced Stage Parkinson's DiseaseUnited States, Albania, Argentina, Brazil, Bulgaria, Canada, Chile, Colombia, Latvia, Lithuania, Peru, Russian Federation, Ukraine
-
AbbVieIQVIA, formerly QuintilesCompletedAdvanced Parkinson's DiseaseUnited Kingdom, Czechia, United States, Australia, Canada, Israel, New Zealand, Poland, Portugal, Russian Federation, Thailand
-
AbbVie (prior sponsor, Abbott)Quintiles, Inc.CompletedAdvanced Parkinson's DiseaseUnited States, Australia, Canada, Czech Republic, Finland, Germany, Israel, Italy, Netherlands, New Zealand, Poland, Portugal, Russian Federation, Spain, Thailand, United Kingdom
-
AbbVieCompletedParkinson's Disease (PD)United States, Australia, Belgium, Canada, Denmark, Germany, Italy, Japan, Netherlands, Russian Federation, Spain, Sweden, United Kingdom
-
Boehringer IngelheimCompletedParkinson DiseaseAustria, Czech Republic, Hungary, India, Italy, Korea, Republic of, Philippines, Poland, Russian Federation, Slovakia, Spain, Sweden, Ukraine, United Kingdom
-
Boehringer IngelheimCompletedParkinson DiseaseAustria, Czech Republic, Hungary, India, Italy, Korea, Republic of, Philippines, Poland, Russian Federation, Slovakia, Spain, Sweden, Ukraine, United Kingdom
-
GlaxoSmithKlineCompletedParkinson DiseaseUnited States, Korea, Republic of, Estonia, Russian Federation, Slovakia, Argentina, Chile
-
Solvay PharmaceuticalsCompletedEarly Stage Parkinson's DiseaseUnited States, Argentina, Belgium, Bulgaria, Canada, Chile, Colombia, Croatia, Finland, India, Israel, Mexico, New Zealand, Peru, Romania, Russian Federation, Serbia, Slovakia, South Africa, Sweden, Ukraine
-
Solvay PharmaceuticalsCompletedEarly Stage Parkinson's DiseaseUnited States, Argentina, Belgium, Bulgaria, Canada, Chile, Colombia, Croatia, Finland, India, Israel, Mexico, New Zealand, Peru, Romania, Russian Federation, Serbia, Slovakia, South Africa, Sweden, Ukraine
-
AlexionSyneos HealthRecruitingAtypical Hemolytic-Uremic SyndromeFrance, Germany, Israel, Italy, United Kingdom, Canada, United States, Australia, Belgium, Denmark, Korea, Republic of, Poland, Russian Federation, Spain, Taiwan
-
ACADIA Pharmaceuticals Inc.CompletedParkinson's Disease PsychosisFrance, United States, Bulgaria, Russian Federation, United Kingdom, Ukraine, India
-
GlaxoSmithKlineCompletedParkinson DiseaseSpain, France, Bulgaria, United Kingdom, Germany, Hungary, Russian Federation, South Africa, Italy, Canada, Czechia, Poland, Romania, Ukraine
-
NeuroDerm Ltd.Active, not recruitingParkinson's DiseaseUnited States, Israel, Spain, France, Russian Federation, Austria, Italy, Belgium, Czechia, Hungary, Netherlands, Poland, Portugal, Slovakia, Ukraine, United Kingdom
-
Boehringer IngelheimCompletedParkinson DiseaseUnited States, Austria, Czech Republic, Finland, France, Germany, Hungary, India, Japan, Malaysia, Netherlands, Russian Federation, Slovakia, Taiwan, Ukraine
-
Boehringer IngelheimCompletedDepression | Parkinson DiseaseAustria, Finland, France, Germany, Italy, Netherlands, Norway, Romania, Russian Federation, South Africa, Spain, Sweden, Ukraine
-
ACADIA Pharmaceuticals Inc.CompletedParkinson's Disease PsychosisUnited States, Austria, France, Canada, Belgium, Russian Federation, Serbia, Ukraine, Poland, Portugal, Italy, India, United Kingdom, Sweden
-
Boehringer IngelheimCompletedEarly Parkinson Disease (Early PD)United States, Argentina, Austria, Czech Republic, Finland, Germany, Hungary, India, Japan, Malaysia, Russian Federation, Slovakia, Taiwan, Ukraine
-
Russian Federation of Anesthesiologists and ReanimatologistsKuban State Medical UniversityRecruitingStroke | Epilepsy | Diabetes | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Neuromuscular Diseases | Parkinson's Disease | Anemia | Coronary Heart Disease | Chronic Heart Failure | Alzheimer's Disease | Bronchial Asthma | Heart Rhythm DisordersRussian Federation
-
Boehringer IngelheimCompletedParkinson DiseaseSlovenia, Romania, Slovakia, Croatia, Czech Republic, Estonia, Hungary, Russian Federation, Serbia
-
Boehringer IngelheimCompletedParkinson DiseaseEstonia, Latvia, Romania, Russian Federation, Serbia, Slovakia, Slovenia, Ukraine
-
Theravance BiopharmaTerminatedParkinson's Disease (PD) | MSA | Symptomatic Neurogenic Orthostatic Hypotension | Pure Autonomic Failure (PAF)United States, Spain, United Kingdom, Canada, France, Estonia, Australia, Israel, Denmark, Italy, Poland, New Zealand, Germany, Ukraine, Austria, Bulgaria, Portugal, Hungary, Russian Federation